The global Next Generation Sequencing (NGS) sample preparation market was valued at USD 12.02 billion in 2022 and, registering a CAGR of 13.1% during the forecast period from 2020 to 2027.

NGS sample preparation is a process that requires sophisticated and automated solutions to prepare target libraries. The process is used to prepare DNA and RNA molecules for sequencing. NGS sample preparation involves various steps such as fragmentation, ligation, size selection, and PCR. The growth of the market is attributed to the increasing prevalence of genetic disorders and the growing demand for personalized medicine.

Drivers

The increasing prevalence of genetic diseases is the primary driver of the NGS sample preparation market. The increasing demand for personalized medicine and the rising investment in the healthcare sector are contributing to the growth of the market. Additionally, technological advancements in the field of NGS sample preparation, government initiatives to promote the adoption of personalized medicine, and the increasing use of NGS sample preparation in research and development activities are expected to further drive the growth of the market.

Restraints

The high cost of NGS sample preparation is anticipated to restrain the market growth. Additionally, the lack of trained medical professionals and the lack of awareness about the availability of NGS sample preparation are some of the factors expected to restrain the market growth.

Opportunities

The increasing demand for NGS sample preparation in applications such as oncology and clinical diagnostics is expected to provide lucrative opportunities for the market growth. Furthermore, the growing adoption of NGS sample preparation in personalized medicine and the increasing focus on the development of point-of-care diagnostics are expected to provide lucrative growth opportunities for the market in the coming years.

Challenges

The lack of adequate reimbursement policies is a major challenge for the market growth. Additionally, the complexity and the time consuming nature of the sample preparation process are expected to hamper the market growth.

Key Segments

By Product Type

• Instruments

• Reagents and Consumables

• Software and Services

By Application

• Diagnostics

• Drug Discovery

• Research and Development

By End User

• Hospitals and Clinics

• Diagnostic Laboratories

• Pharmaceutical and Biotechnology Companies

• Other End Users

By Region

• North America

• Europe

• Asia-Pacific

• Latin America

• Middle East and Africa

Key Players

• Illumina, Inc.

• Thermo Fisher Scientific Inc.

• QIAGEN N.V.

• Agilent Technologies, Inc.

• Oxford Nanopore Technologies Ltd.

• BGI

• F. Hoffmann-La Roche AG

• Eurofins Scientific SE

• Macrogen, Inc.

• DNASTAR, Inc.